Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-03-13
2000-03-07
Kemmerer, Elizabeth
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530350, 530399, 930120, A61K 3818, C07K 1451
Patent
active
060340622
ABSTRACT:
Purified Bone Morphogenetic Protein (BMP)-9 proteins and processes for producing them are disclosed. The proteins may be used in the treatment of bone and cartilage defects and in wound healing and related tissue repair, and in hepatic growth and function.
REFERENCES:
patent: 4294753 (1981-10-01), Urist
patent: 4434094 (1984-02-01), Seyedin et al.
patent: 4455256 (1984-06-01), Urist
patent: 4563350 (1986-01-01), Nathan
patent: 4608199 (1986-08-01), Caplan et al.
patent: 4619989 (1986-10-01), Urist
patent: 4627982 (1986-12-01), Seyedin et al.
patent: 4681763 (1987-07-01), Nathanson
patent: 4737578 (1988-04-01), Evans
patent: 4761471 (1988-08-01), Urist
patent: 4774228 (1988-09-01), Seyedin
patent: 4774322 (1988-09-01), Seyedin
patent: 4789732 (1988-12-01), Urist
patent: 4795804 (1989-01-01), Urist
patent: 4798885 (1989-01-01), Mason
patent: 4804744 (1989-02-01), Sen
patent: 4810691 (1989-03-01), Seyedin
patent: 4843063 (1989-06-01), Seyedin
patent: 4886747 (1989-12-01), Derynck
patent: 4968590 (1990-11-01), Kuberasampath et al.
patent: 5011691 (1991-04-01), Oppermann
patent: 5106626 (1992-04-01), Parsons et al.
patent: 5108753 (1992-04-01), Kuberasampath
patent: 5661007 (1997-08-01), Wozney et al.
Sporn et al. 1988. Peptide growth factors are multifunctional. Nature, vol. 332, pp. 217-219, Mar. 1988.
Baird et al. 1986. Inhibition of endothelial cell proliferation by type-beta transforming growth factor: interactions with acidic and basic fibroblast growth factors. Biochem. Biophys. Res. Commun. vol. 138, pp. 476-482, Jul. 1986.
Roberts et al. 1986. Transforming growth factor type-beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA, vol. 83, pp. 4167-4171, Jun. 1986.
Shipley et al. 1986. Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-gorwth inhitor in serum-free medium. Cancer Res., vol. 46, pp. 2068-2071, Apr. 1986.
Beck et al. 1990. Accelerated healing of ulcer wounds in the rabbit ear by recombinant human transforming grrowth-beta 1. Growth Factors, vol. 2, pp. 273-282, Feb. 1990.
Nathan C; Sporn M. Cyokines in context. Journal of Cell Biology, (Jun. 1991 113 (5) 981-986.
Wozney et al. 1988. Novel regulators of bone formation: molecular clones and activities. Science, (Dec. 16, 1988) 242 (4885) 1528-1534.
Wozeny et al, pp. 725-748 in Handbook of Exp. Pharm., vol. 107 (Springer-Verlag, Berlin, 1993).
Wang et al, "Recombinant human bone morphogenetic protein . . . " PNAS 87: 2220-2224, Mar. 1990.
Celeste et al "Identification of transforming growth factor & family members . . . ", PNAS 87: 9843-9847 (Dec. 1990).
Wozney et al, "Novel Regulation of Bone Formation..." Science 242: 1528-1534 (Dec. 1988).
Burt et al, "Evolutionary Grouping of the Transforming Growth Factor-.crclbar.Superfamily", BBRC 184(2): 590-595 (Apr. 1992).
Wozney et al, "Growth factors influencing bone development", J. Cell Sci. Suppl. 13: 149-156, 1990.
Wozney, J. M. et al. (1988) "Novel Regulators of Bone Formation Molecular Clones and Activities", Science, vol. 242, pp. 1528-1533.
Urist et al., Science 220: 680-686 (1983).
Luyten et al., The Journal of Biological Chemistry 264(23):3377-13380 (1989).
Sampath et al., Proc. Natl Acad. Sci 84:7109-7113 (1987).
Ozkaynak et al., The EMBO Journal v. 9 No. 7:2085-2093 (1990).
Hammonds et al., Molecular Endocrinology 5:149-155 (1991).
Celeste et al., J. of Bone Mineral Res. v. 9 suppl. 5136 (1994).
Celeste et al., Proc. Natl. Acad. Sci. 87:9843-9847 (1990).
Burt et al., BBRC 184(2):590-595 (1992).
Wozney et al., J. Cell Sci. Suppl. 13:149-156 (1990).
Wang et al., Proc. Natl.. Acad. Sci. 87:220-2224 (1990).
Hebda et al. 1988. Stimulatory effects of transforming growth factor-beta and epidermal growth factor on epidermal cell outgrowth from porcine skin expalnt cultures. J. Invest. Dermatol., vol. 91, pp. 440-445, Nov. 1988.
McDonald et al. 1993. A structural superfamily of growth factors containing a cystine knot motif. Cell, vol. 73, pp. 421-424, May 1993.
Song Jeffrey J.
Thies R. Scott
Genetics Institute Inc.
Kapinos Ellen J.
Kemmerer Elizabeth
Mienert M. C.
Romeo David S.
LandOfFree
Bone morphogenetic protein (BMP)-9 compositions and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bone morphogenetic protein (BMP)-9 compositions and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bone morphogenetic protein (BMP)-9 compositions and their uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-363150